Sec Form 13G Filing - bioMerieux @ Quanterix Corp

Sec Form 13G Filing - bioMerieux filing for Quanterix Corp (QTRX) - 2019-11-18

Insider filing report for Changes in Beneficial Ownership

Schedule 13G & 13D forms are used to report a party's ownership of stock which exceeds 5% of a company's total stock issue.
Schedule 13G is a shorter version of Schedule 13D with fewer reporting requirements.

"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

SCHEDULE 13G/A

Under the Securities Exchange Act of 1934

(Amendment No. 1 – Exit Filing)*

Quanterix Corporation

(Name of Issuer)

Common Stock

(Title of Class of Securities)

74766Q101

(CUSIP Number)

November 7, 2019

(Date of Event Which Requires Filing of this Statement)

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

☐ Rule 13d-1(b)

☐ Rule 13d-1(c)

☒ Rule 13d-1(d)

*	The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page.

The information required in the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act, but shall be subject to all other provisions of the Act (however, see the Notes).


CUSIP No. 74766Q101

Item 1(a).

Name of Issuer

Quanterix Corporation (the “Issuer”).

Item 1(b).

Address of Issuer’s Principal Executive Offices

900 Middlesex Turnpike

Billerica, MA 01821

Item 2(a).

Name of Person Filing

bioMérieux SA

Item 2(b).

Address of Principal Business Office or, if none, Residence

376 Chemin de l’Orme, 69280 Marcy l’Étoile, France

Item 2(c).

Citizenship

France

Item 2(d).

Title of Class of Securities

Common stock, par value $0.001 per share.

Item 2(e).

CUSIP Number

74766Q101.

Item 3.

If This Statement Is Filed Pursuant to Sections 240.13d-1(b) or 240.13d-2(b) or (c), Check Whether the Person Filing Is a(n):

Not Applicable.

Item 4.

Ownership

(a)

Amount beneficially owned:

0 shares of Common Stock.

(b)

Percent of class:

(c)

Number of shares as to which such person has:

(i)

Sole power to vote or to direct the vote:

(ii)

Shared power to vote or to direct the vote:

(iii)

Sole power to dispose or to direct the disposition:

(iv)

Shared power to dispose or to direct the disposition:

Item 5.

Ownership of Five Percent or Less of a Class

If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than 5 percent of the class of securities, check the following: ☒

Item 6.

Ownership of More Than Five Percent on Behalf of Another Person

Not Applicable.

Item 7.

Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on By the Parent Holding Company

Not Applicable.

Item 8.

Identification and Classification of Members of the Group

Not Applicable.

Item 9.

Notice of Dissolution of Group

Not Applicable.

Item 10.

Certifications

Not Applicable.

SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

Dated: November 18, 2019


		BIOMÉRIEUX SA

By		/s/ Alexandre Mérieux


Name:		Alexandre Mérieux
Title:		Chief Executive Officer

NAMES OF REPORTING PERSONS

bioMérieux SA

CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*

(a) ☐ (b) ☐

SEC USE ONLY

CITIZENSHIP OR PLACE OF ORGANIZATION

France